{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-001616","form_type":"8-K/A","ticker":"PETV","cik":"0001512922","company_name":"PetVivo Holdings, Inc.","filed_at":"2025-03-31T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.846291+00:00","generated_at":"2026-05-24T01:43:32.401846+00:00","sec_items":["1.01","3.02","5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"PetVivo raises $5M via Series B Convertible Preferred Stock; initial $600K funded","bullets":["$5M Series B Convertible Preferred offering at $1.00/share; $600K initial, option for additional $4.4M.","Preferred stock carries 10% annual dividend payable in common stock; shares convertible 1:1 into common.","Company call option after 2 years at $1.15/share; holder may convert during 30-day call period.","Proceeds for commercialization of Spryng™ and PrecisePRP, clinical trials, and working capital.","Filed Certificate of Designation for Series B Preferred with Nevada Secretary of State."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-001616","json":"https://secwatch.observer/filing/0001641172-25-001616.json","markdown":"https://secwatch.observer/filing/0001641172-25-001616.md","text":"https://secwatch.observer/filing/0001641172-25-001616.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1512922/000164117225001616/0001641172-25-001616-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1512922/000164117225001616/form8-ka.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T01:43:32.401846+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}